The Effect of Aronia Melanocarpa Extract on Cognitive Function
The Effect of Short-term Aronia Melanocarpa Extract Supplementation on Cognitive Function in Healthy Young Adults
1 other identifier
interventional
36
1 country
1
Brief Summary
There is a great interest in improving cognitive performance, including memory and attention. Improved attention is desirable for a large group of people because it is linked to improved performance . Students and professionals can benefit from improved attention and thus performance in academic and other work environments. In addition, cognitive functioning also plays an important role in sports. Various cognitive skills, including attention, reaction time and motor function, have shown that they can influence sport performance. A completely natural supplement with aronia melanocarpa extract could be a promising way to naturally improve cognitive performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2018
CompletedFirst Posted
Study publicly available on registry
January 4, 2019
CompletedStudy Start
First participant enrolled
October 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2021
CompletedSeptember 5, 2021
September 1, 2020
7 months
December 19, 2018
September 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive function
CANTAB
After 7 days of supplementation
Secondary Outcomes (5)
Mood
After 7 days of supplementation
Biomarkers in blood and saliva
After 7 days of supplementation
Vascular function
After 7 days of supplementation
Microvasculature
After 7 days of supplementation
Subjective cognition
After 7 days of supplementation
Study Arms (2)
placebo
PLACEBO COMPARATORmicrocrystalline cellulose supplementation
Aronia
EXPERIMENTALaronia melanocarpa supplementation
Interventions
Eligibility Criteria
You may qualify if:
- Healthy young adults: ages between 18 and 35
- BM between 18.5-30 kg/m2
You may not qualify if:
- Current use of (antioxidant) dietary supplements and not willing to quit for the duration of the study duration
- Pre-existing or history of neurological illness
- High blood pressure (\>140 systolic and/or \>90 diastolic mmHg)
- Use of medication that might have influence on endpoints (e.g. antidepressant)
- Known pregnancy or lactation
- Food allergy to the study product
- Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study, to be decided by the principle investigator, in the 180 days prior to the study
- Abuse of products (\> 20 alcoholic consumptions per week and drug usage)
- Participation in a scientific intervention study which may interfere with this study in the 180 days prior to this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- BioActor B.V.collaborator
Study Sites (1)
Maastricht University
Maastricht, Limburg, 6229ET, Netherlands
Related Publications (1)
Ahles S, Joris PJ, Plat J. Short-term Aronia melanocarpa extract supplementation improves cognitive performance: a randomized, double-blind, placebo-controlled cross-over study in healthy young adults. Eur J Nutr. 2024 Aug;63(5):1545-1553. doi: 10.1007/s00394-024-03381-3. Epub 2024 Apr 24.
PMID: 38656355DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jogchum Plat, Prof
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- block randomization
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2018
First Posted
January 4, 2019
Study Start
October 9, 2020
Primary Completion
April 29, 2021
Study Completion
April 29, 2021
Last Updated
September 5, 2021
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share